Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

RITE AID CORPORATION (RAD)
My previous session
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

Rite Aid : Deal Lifts Walgreens Pharmacy

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/12/2018 | 08:48am CEST

By Kimberly Chin

Walgreens Boots Alliance Inc. said growth in prescription volumes helped lift pharmacy sales in its latest quarter, as the company's integration of Rite Aid stores expanded its foothold in the U.S. prescription market.

Walgreens's share of the U.S. retail prescription market this year has grown to a company record 21.7%, compared with 20.2% in 2017, Walgreens Chief Financial Officer James Kehoe said Thursday, citing data from health-care research firm Iqvia.

For the fourth quarter, Walgreens said it had filled the largest number of prescriptions in its 117-year history, largely because of its retention of many Rite Aid prescription-drug customers after taking over those stores. Walgreens closed a $4.4 billion deal earlier this year to buy more than 1,900 pharmacies from Rite Aid Corp.

Walgreens, based in Deerfield, Ill., said U.S. pharmacy sales rose 17% from the year-earlier quarter while prescriptions filled in comparable stores increased 1.3%. Overall sales rose 11% to $33.44 billion, though analysts had expected Walgreens to report $33.78 billion in sales based on a Refinitiv poll.

The drugstore chain has engaged in several deals and partnerships with the aim of expanding its pharmacy business to become a "health-care destination" for health, beauty and personal care, said Chief Executive Stefano Pessina.

Walgreens reached a deal in September to buy customer files from a group of stores that are part of the Fred's Inc. drugstore chain. This month, Walgreens said it would work with clinical-lab operator LabCorp, known formally as Laboratory Corp. of America Holdings, to open at least 600 LabCorp patient centers at its stores over the next four years. It also reached an agreement with Kroger Co., the nation's largest supermarket chain, to work together to pilot a new store format. The company has also looked to boost its beauty aisles with high-end cosmetics after taking a minority stake in beauty startup Birchbox Inc.

Growth in Walgreens's pharmacy business helped offset weakness in sales of general merchandise and personal-care items. Comparable retail sales in the fourth quarter fell 1.9% from a year earlier in the U.S., and 0.9% in the company's international segment on a constant-currency basis. The company has more than 18,500 stores across 11 countries.

Shares in Walgreens were up 1.5% at $73.40 at midday Thursday.

Net income for the company rose 89% to $1.51 billion, or $1.55 a share. On an adjusted basis, earnings per share came in at $1.48, above the $1.45 expected by analysts.

For the current fiscal year Walgreens forecast earnings growth between 7% and 12% at constant currency rates, and adjusted earnings per share in the range of $6.40 to $6.70. Analysts expect adjusted earnings of $6.45 a share.

Write to Kimberly Chin at kimberly.chin@wsj.com

Stocks mentioned in the article
ChangeLast1st jan.
RITE AID CORPORATION 2.86% 1.08 Delayed Quote.-46.19%
WALGREENS BOOTS ALLIANCE 2.09% 76.28 Delayed Quote.1.21%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
10/16RITE AID : Offering Free Advisor Tool to Help Medicare Beneficiaries Choose Pres..
BU
10/12RITE AID : Deal Lifts Walgreens Pharmacy
DJ
10/11WALGREENS BOOTS ALLIANCE : Sales Growth Falls Short -- 2nd Update
DJ
10/11WALGREENS BOOTS ALLIANCE : Sales Growth Falls Short--Update
DJ
10/11WALGREENS BOOTS ALLIANCE : tops 4Q expectations, helped by Rite Aid deal
AQ
10/04RITE AID : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
10/04RITE AID : Foundation Launches Prescription Drug Safety Initiative in Seattle-Ar..
BU
10/04RITE AID : Former Rite Aid VP pleads guilty in $5.7M kickback scheme
AQ
10/04RITE AID : Former Rite Aid VP pleads guilty in $5.7M kickback scheme
AQ
10/03RITE AID : Applauds Passage of Legislation Helping Seniors Access Pharmacy Servi..
BU
More news
News from SeekingAlpha
10/15RITE AID LEADERSHIP :  Epic Fail 
10/15Moody's cautious on Rite Aid 
10/11Why Rite Aid Shareholders Must Vote As Shares Fall Toward The $1 Range 
10/07Kroger And Walgreens Team Up For Pickup 
09/27Rite Aid Corporation (RAD) CEO John Standley on Q2 2019 Results - Earnings Ca.. 
Financials ($)
Sales 2019 21 807 M
EBIT 2019 213 M
Net income 2019 -458 M
Debt 2019 2 923 M
Yield 2019 -
P/E ratio 2019 -
P/E ratio 2020
EV / Sales 2019 0,19x
EV / Sales 2020 0,18x
Capitalization 1 131 M
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 7
Average target price 1,31 $
Spread / Average Target 25%
EPS Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kermit R. Crawford President & Chief Operating Officer
Darren W. Karst Chief Financial & Administrative Officer, SEVP
Joseph B. Anderson Independent Director
Marcy Syms Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-46.19%1 131
RAIA DROGASIL-26.01%5 906
PALTAC CORP-6.01%2 851
AIN HOLDINGS INC25.96%2 676
GALENICA AG4.10%2 619
QOL CO., LTD.10.26%829